Janus Henderson Investors US’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Janus Henderson Investors US’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$65.2M	Buy	4,409,717 +717,643	+19%	+$11.6M	0.05%	376
2016 Q4	$59.7M	Sell	3,692,074 -123,739	-3%	-$2.24M	0.05%	403
2016 Q3	$69.2M	Sell	3,815,813 -225,931	-6%	-$4.41M	0.06%	365
2016 Q2	$66.6M	Sell	4,041,744 -378,266	-9%	-$6.12M	0.06%	371
2016 Q1	$73.2M	Buy	4,420,010 +1,246,752	+39%	+$21.8M	0.06%	346
2015 Q4	$68.8M	Buy	3,173,258 +350,092	+12%	+$6.81M	0.06%	347
2015 Q3	$56M	Buy	2,823,166 +1,929,471	+216%	+$61M	0.05%	385
2015 Q2	$31M	Buy	+893,695	New	+$27.3M	0.03%	525

Other funds holding HZNP

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return